Open access
Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer
M. Scholtes
E. Koedoot
Lieke J. Ceton
T. Sijsenaar
M. G. Montero
C. Z. Roeland
R. V. van Soest
Joost A. P. Leijte
H. Roshani
R. Korthorst
Dieudonne van der Meer
G. V. van Leenders
W. Vader
J. Boormans
T. Zuiverloon
Medicine
Abstract
Take Home Message Ex vivo three-dimensional microtumor testing shows promise in predicting chemotherapy response in patients with bladder cancer within clinical timelines, highlighting its potential to serve as a clinical biomarker to guide treatment decision-making.